| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.39 | 0.02 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.22 | 1e-08 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.2 | 0.5 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |